Exosome-mediated delivery of miR-9 induces cancer-Associated fibroblast-like properties in human breast fibroblasts

Cell Death and Disease

Volumn 7, Issue 7, 2016, Pages

  Baroni, S ^a   Romero Cordoba, S ^b   Plantamura, I ^a   Dugo, M ^a   D'Ippolito, E ^a   Cataldo, A ^a   Cosentino, G ^a   Angeloni, V ^a   Rossini, A ^a   Daidone, M G ^a   Iorio, M V ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INMGEN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 9; UVOMORULIN; CADHERIN; MICRORNA; MIRN92 MICRORNA, HUMAN; TRANSCRIPTOME;

ARTICLE; BREAST CANCER CELL LINE; CANCER ASSOCIATED FIBROBLAST; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EXOSOME; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TRANSIENT TRANSFECTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BREAST; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; BREAST; CADHERINS; CANCER-ASSOCIATED FIBROBLASTS; CELL LINE, TUMOR; CELL MOVEMENT; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, SCID; MICRORNAS; PHENOTYPE; TRANSCRIPTOME; TRANSFECTION; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 85016300637     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.224     Document Type: Article

References (38)

1. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 2006; 5: 1597-1601.
2. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
3. Rozenchan PB, Carraro DM, Brentani H, de Carvalho Mota LD, Bastos EP, Ferreira EN et al. Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer 2009; 125: 2767-2777.
4. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004; 6: 17-32.
5. Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 2009; 114: 47-62.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
7. Boyle P. Triple-negative breast cancer: Epidemiological considerations and recommendations. Ann Oncol 2012; 23 (Suppl 6):vi7-vi12.
8. Qiao A, Gu F, Guo X, Zhang X, Fu L. Breast cancer-Associated fibroblasts: Their roles in tumor initiation, progression and clinical applications. Front Med 2016; 10: 33-40.
9. Cortez E, Roswall P, Pietras K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin Cancer Biol 2014; 25: 3-9.
10. Park SY, Kim HM, Koo JS. Differential expression of cancer-Associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat 2015; 149: 727-741.
11. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-159.
12. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25: 501-515.
13. Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo H et al. MiRNA expression analysis of cancerassociated fibroblasts and normal fibroblasts in breast cancer. Int J Biochem Cell Biol 2012; 44: 2051-2059.
14. Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME et al. MicroRNAs reprogram normal fibroblasts into cancer-Associated fibroblasts in ovarian cancer. Cancer Discov 2012; 2: 1100-1108.
15. Tang X, Hou Y, Yang G, Wang X, Tang S, Du YE et al. Stromal miR-200 s contribute to breast cancer cell invasion through CAF activation and ECM remodeling. Cell Death Differ 2016; 23: 132-145.
16. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-688.
17. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D et al. miR-9, a MYC/MYCN-Activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12: 247-256.
18. Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012; 31: 3513-3523.
19. Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat 2014; 147: 39-49.
20. Peng Q, Zhao L, Hou Y, Sun Y, Wang L, Luo H et al. Biological characteristics and genetic heterogeneity between carcinoma-Associated fibroblasts and their paired normal fibroblasts in human breast cancer. PLoS One 2013; 8: E60321.
21. Angelucci C, Maulucci G, Lama G, Proietti G, Colabianchi A, Papi M et al. Epithelial-stromal interactions in human breast cancer: Effects on adhesion, plasma membrane fluidity and migration speed and directness. PLoS One 2012; 7: E50804.
22. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006; 25: 6202-6210.
23. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M et al. The role of miR-31 and its target gene SATB2 in cancer-Associated fibroblasts. Cell Cycle 2010; 9: 4387-4398.
24. Bauer M, Su G, Casper C, He R, Rehrauer W, Friedl A. Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 2010; 29: 1732-1740.
25. Strongin AY. Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta 2010; 1803: 133-141.
26. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14: 518-527.
27. Li Y, Cai G, Yuan S, Jun Y, Li N, Wang L et al. The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer. Am J Transl Res 2015; 7: 120-127.
28. Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, Betz B et al. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 2009; 124: 1727-1735.
29. Tian H, Liu J, Chen J, Gatza ML, Blobe GC. Fibulin-3 is a novel TGF-beta pathway inhibitor in the breast cancer microenvironment. Oncogene 2015; 34: 5635-5647.
30. Dzobo K, Leaner VD, Parker MI. Absence of feedback regulation in the synthesis of COL1A1. Life Sci 2014; 103: 25-33.
31. Kim SH, Lee HY, Jung SP, Kim S, Lee JE, Nam SJ et al. Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines. Oncol Lett 2014; 8: 507-512.
32. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
33. Buchsbaum RJ, Oh SY. Breast cancer-Associated fibroblasts: Ehere we are and where we need to go. Cancers (Basel) 2016; 8: E19.
34. Orimo A, Gupta PB, Sgroi DC, renzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
35. Du P, Kibbe WA, Lin SM. lumi: A pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
36. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118-127.
37. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
38. McCall MN, Bolstad BM, Irizarry RA. Frozen robust multiarray analysis (fRMA). Biostatistics 2010; 11: 242-253.